945
Participants
Start Date
August 25, 2020
Primary Completion Date
November 21, 2023
Study Completion Date
November 21, 2023
Meningococcal Group B Vaccine (GSK3536829A) (rMenB+OMV NZ)
1 dose of rMenB+OMV administered intramuscularly at day 1 and 61 to participants in MenB+MenACWY group and MenB group and as 1 dose at day 91 to participants in MenACWY group.
Meningococcal MenACWY Conjugate Vaccine (GSK3536820A) (MenA lyo + MenCWY liquid)
1 dose of MenACWY administered intramuscularly at day 1 to participants in MenB+MenACWY group and MenACWY group, 1 dose at day 91 to participants for MenB group.
Placebo
1 dose of Placebo administered intramuscularly at 1 to participants in MenB group and MenACWY group and as 1 dose at day 91 to participants in MenB+MenACWY group.
GSK Investigational Site, Cortland
GSK Investigational Site, Pittsburgh
GSK Investigational Site, Pittsburgh
GSK Investigational Site, Pittsburgh
GSK Investigational Site, Pittsburgh
GSK Investigational Site, Chiavari GE
GSK Investigational Site, Hermitage
GSK Investigational Site, Erie
GSK Investigational Site, Milan
GSK Investigational Site, Milan
GSK Investigational Site, Falls Church
GSK Investigational Site, Richmond
GSK Investigational Site, Winston-Salem
GSK Investigational Site, Charlotte
GSK Investigational Site, Charleston
GSK Investigational Site, Wellington
GSK Investigational Site, Bardstown
GSK Investigational Site, Louisville
GSK Investigational Site, Evansville
GSK Investigational Site, Sioux Falls
GSK Investigational Site, Lincoln
GSK Investigational Site, Lincoln
GSK Investigational Site, Lincoln
GSK Investigational Site, Lincoln
GSK Investigational Site, Lafayette
GSK Investigational Site, Foggia
GSK Investigational Site, Austin
GSK Investigational Site, Plano
GSK Investigational Site, Plano
GSK Investigational Site, Waxahachie
GSK Investigational Site, Dallas
GSK Investigational Site, Houston
GSK Investigational Site, Victoria
GSK Investigational Site, Austin
GSK Investigational Site, Austin
GSK Investigational Site, Nampa
GSK Investigational Site, Nampa
GSK Investigational Site, Boise
GSK Investigational Site, Orem
GSK Investigational Site, Syracuse
GSK Investigational Site, South Jordan
GSK Investigational Site, Salt Lake City
GSK Investigational Site, Phoenix
GSK Investigational Site, Los Angeles
GSK Investigational Site, Bell Gardens
GSK Investigational Site, Walnut Creek
GSK Investigational Site, Oakland
GSK Investigational Site, Santa Clara
GSK Investigational Site, San Jose
GSK Investigational Site, Roseville
GSK Investigational Site, Sacramento
GSK Investigational Site, Corvallis
GSK Investigational Site, Dallas
Lead Sponsor
GlaxoSmithKline
INDUSTRY